|
Year of Diagnosis |
Total | In Situ | Localized | Regional | Distant | Unknown | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Number | Percent | Number | Percent | Number | Percent | Number | Percent | Number | Percent | ||
| 2016-2020 | 160 | - | - | 102 | 63.8 | 21 | 13.1 | 18 | 11.3 | 19 | 11.9 |
| 2015-2019 | 145 | - | - | 86 | 59.3 | 22 | 15.2 | 17 | 11.7 | 20 | 13.8 |
| 2014-2018 | 143 | - | - | 89 | 62.2 | 21 | 14.7 | 14 | 9.8 | 19 | 13.3 |
| 2013-2017 | 124 | - | - | 79 | 63.7 | 15 | 12.1 | 12 | 9.7 | 18 | 14.5 |
| 2012-2016 | 116 | - | - | 79 | 68.1 | 10 | 8.6 | 9 | 7.8 | 18 | 15.5 |
| 2011-2015 | 108 | - | - | 78 | 72.2 | 12 | 11.1 | 7 | 6.5 | 11 | 10.2 |
| 2010-2014 | 113 | - | - | 88 | 77.9 | 14 | 12.4 | 4 | 3.5 | 7 | 6.2 |
| 2009-2013 | 110 | - | - | 86 | 78.2 | 13 | 11.8 | 4 | 3.6 | 7 | 6.4 |
| 2008-2012 | 122 | - | - | 96 | 78.7 | 14 | 11.5 | 4 | 3.3 | 8 | 6.6 |
| 2007-2011 | 135 | - | - | 109 | 80.7 | 19 | 14.1 | 3 | 2.2 | 4 | 3.0 |
| 2006-2010 | 150 | - | - | 122 | 81.3 | 19 | 12.7 | 4 | 2.7 | 5 | 3.3 |
| 2005-2009 | 146 | - | - | 121 | 82.9 | 14 | 9.6 | 5 | 3.4 | 6 | 4.1 |
| 2004-2008 | 163 | - | - | 134 | 82.2 | 17 | 10.4 | 7 | 4.3 | 5 | 3.1 |
| 2003-2007 | 173 | - | - | 144 | 83.2 | 17 | 9.8 | 7 | 4.0 | 5 | 2.9 |
| 2002-2006 | 172 | 1 | 0.6 | 141 | 82.0 | 13 | 7.6 | 8 | 4.7 | 9 | 5.2 |
| 2001-2005 | 164 | 1 | 0.6 | 132 | 80.5 | 11 | 6.7 | 6 | 3.7 | 14 | 8.5 |
| 2000-2004 | 159 | 1 | 0.6 | 129 | 81.1 | 11 | 6.9 | 6 | 3.8 | 12 | 7.5 |
| 1999-2003 | 147 | 2 | 1.4 | 115 | 78.2 | 9 | 6.1 | 4 | 2.7 | 17 | 11.6 |
| 1998-2002 | 144 | 2 | 1.4 | 111 | 77.1 | 7 | 4.9 | 4 | 2.8 | 20 | 13.9 |
| 1997-2001 | 137 | 1 | 0.7 | 102 | 74.5 | 7 | 5.1 | 5 | 3.6 | 22 | 16.1 |
| 1996-2000 | 134 | 1 | 0.7 | 99 | 73.9 | 7 | 5.2 | 5 | 3.7 | 22 | 16.4 |
| 1995-1999 | 134 | 1 | 0.7 | 96 | 71.6 | 6 | 4.5 | 5 | 3.7 | 26 | 19.4 |
| 1994-1998 | 145 | - | - | 95 | 65.5 | 13 | 9.0 | 8 | 5.5 | 29 | 20.0 |
| 1993-1997 | 145 | - | - | 81 | 55.9 | 20 | 13.8 | 9 | 6.2 | 35 | 24.1 |
| 1992-1996 | 161 | - | - | 79 | 49.1 | 23 | 14.3 | 10 | 6.2 | 49 | 30.4 |
| 1991-1995 | 170 | 1 | 0.6 | 89 | 52.4 | 23 | 13.5 | 12 | 7.1 | 45 | 26.5 |
| 1990-1994 | 173 | 1 | 0.6 | 87 | 50.3 | 27 | 15.6 | 11 | 6.4 | 47 | 27.2 |
| 1989-1993 | 166 | 1 | 0.6 | 89 | 53.6 | 17 | 10.2 | 9 | 5.4 | 50 | 30.1 |
| 1988-1992 | 164 | 1 | 0.6 | 88 | 53.7 | 14 | 8.5 | 10 | 6.1 | 51 | 31.1 |
| 1987-1991 | 142 | 1 | 0.7 | 85 | 59.9 | 13 | 9.2 | 10 | 7.0 | 33 | 23.2 |
| 1986-1990 | 127 | - | - | 65 | 51.2 | 14 | 11.0 | 11 | 8.7 | 37 | 29.1 |
| 1985-1989 | 116 | - | - | 57 | 49.1 | 12 | 10.3 | 15 | 12.9 | 32 | 27.6 |
| Notes: |
|---|
|
In Situ Stage represents the presence of malignant cells within the cell group from which they arose, with no penetration of basement membrane of the tissue and no stromal invasion. |
| Localized Stage represents invasive cancer confined to the organ of origin or intralumenal extension where specified as an intralumenal extension to immediately contiguous segments of the large bowel. |
| Regional Stage represents direct extension to adjacent organs or tissues or involvement of the regional lymph nodes. |
| Distant Stage represents direct continuity to non-adjacent organs, discontinuous metastasis or involvement of the distant lymph nodes. |
| COVID-19 Pandemic: In 2020, the highly publicized impact of the COVID-19 pandemic on health services and the consequential delays and reductions in cancer screening and diagnosis led to a decline in the 2020 incidence rates for most cancer sites. Because 2020 was a temporary, anomalous year, it can bias estimates such as cancer incidence trends. |
| Source : Michigan Resident Cancer Incidence File. Updated with cases processed through November 30, 2022. Division for Vital Records & Health Statistics, Michigan Department of Health & Human Services. |
|
Last Updated : April 13, 2023 |